| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

Status of COVID-19 Medicines and Active Pharmaceutical Ingredients (APIs) updated

Announcement

3 October, 2022 - 19:45 (CEST)

WHO list of prequalified in vitro diagnostic products updated

IVD

Announcement

29 September, 2022 - 21:20 (CEST)

First molnupiravir active pharmaceutical ingredient (API) prequalified

Announcement

29 September, 2022 - 21:10 (CEST)

Molnupiravir (WHOAPI-451) manufactured by Divi’s Laboratories Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalif

WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated

IVD

Announcement

29 September, 2022 - 17:45 (CEST)

WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated

IVD

Announcement

28 September, 2022

New WHO Public Inspection Reports (WHOPIRs) published

Alerts

26 September, 2022 - 20:50 (CEST)

WHO Public Assessment Reports (WHOPARs) published

Announcement

26 September, 2022 - 19:48 (CEST)

WHO Public Assessment Reports (WHOPARs) published

Announcement

22 September, 2022 - 20:14 (CEST)

WHO list of prequalified in vitro diagnostic products updated

IVD

Alerts

22 September, 2022 - 14:45 (CEST)

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process updated

Alerts

22 September, 2022 - 00:30 (CEST)

Subscribe to